Christiane Damgé

Pharmacology, Toxicology and Pharmaceutics · Life Sciences

26h-index3.1kcitations67works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Advanced Drug Delivery Systems(20), Drug Solubulity and Delivery Systems(11), Diabetes Management and Research(11), Neuropeptides and Animal Physiology(10), Pancreatic function and diabetes(10)

Publications66 total

Nanotechnology for Oral Drug Delivery and Targeting
2016· 1 cited
Nanotechnology for Oral Drug Delivery and Targeting
2016· 1 cited
Reduction of the in vivo burst release of insulin-loaded microparticles
Journal of Drug Delivery Science and Technology·2015· 26 cited
Nanotechnology as a Promising Strategy for Alternative Routes of Insulin Delivery
Methods in enzymology on CD-ROM/Methods in enzymology·2012· 40 cited
Effects of an oral insulin nanoparticle administration on hepatic glucose metabolism assessed by<sup>13</sup>C and<sup>2</sup>H isotopomer analysis
Journal of Microencapsulation·2011· 3 cited
Recent Advances in Drug Delivery Systems
Journal of Biomaterials and Nanobiotechnology·2011· 234 citedOpen Access
P173 Effets d’un entraînement en endurance sur les capacités à l’exercice et la fonction mitochondriale de rats diabétiques de type 1
Diabetes & Metabolism·2010
Influence of polymers ratio on insulin-loaded nanoparticles based on poly-ε-caprolactone and Eudragit<sup>®</sup>RS for oral administration
Drug Delivery·2009· 17 citedOpen Access
Stealth nanoparticles coated with heparin as peptide or protein carriers
Journal of drug targeting·2009· 32 cited
Poly(ε-caprolactone)/eudragit nanoparticles for oral delivery of aspart-insulin in the treatment of diabetes
Journal of Pharmaceutical Sciences·2009· 84 cited
Nanoparticulate biopolymers deliver insulin orally eliciting pharmacological response
Journal of Pharmaceutical Sciences·2008· 96 cited
Polyelectrolyte Biomaterial Interactions Provide Nanoparticulate Carrier for Oral Insulin Delivery
Drug Delivery·2008· 79 cited
Toxicological assessment of orally delivered nanoparticulate insulin
Nanotoxicology·2008· 36 cited
PHARMACEUTICAL NANOTECHNOLOGY Nanoparticulate Biopolymers Deliver Insulin Orally Eliciting Pharmacological Response
2008
Nanoparticle strategies for the oral delivery of insulin
Expert Opinion on Drug Delivery·2007· 135 cited
Effect of angiotensin‐converting enzyme inhibition on skeletal muscle oxidative function and exercise capacity in streptozotocin‐induced diabetic rats
Experimental Physiology·2007· 17 citedOpen Access
Oral delivery of insulin associated to polymeric nanoparticles in diabetic rats
Journal of Controlled Release·2006· 346 cited
Effect of epiregulin on pancreatic beta cell growth and insulin secretion
Growth Factors·2005· 17 cited
Formulation of Insulin-Loaded Polymeric Nanoparticles Using Response Surface Methodology
Drug Development and Industrial Pharmacy·2005· 51 cited
Cholecystokinin octapeptide: a potential growth factor for pancreatic beta cells in diabetic rats.
PubMed·2004· 39 cited
page 1 of 4Next →

Frequent Co-authors

Marc Aprahamian(23), Amor Hajri(10), Philippe Maincent(8), Ginette Balboni(8), Catarina Pinto Reis(7), M. Pinget(7), Serge Évrard(6), Jacques Marescaux(6), Christine Michel(5), Patrick Couvreur(5), Francisco Veiga(4), Ronald J. Neufeld(4), M. Socha(4), André Hoeltzel(4), Nathalie Ubrich(3), J.P. Devissaguet(3), António J. Ribeiro(3), Emmanuelle Kuntz(3), A. Sapin(3), Didier Mutter(3)